Skip to main content
SpringerLink
Log in

Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

This study compared the course of midtrimester termination of pregnancies with fetal demise and those with a viable fetuses by extra-amniotic prostaglandin (PG) E2. A total of 275 women who underwent second trimester abortion with extra-amniotic PGE22 were divided into two groups: 95 patients (35%) with fetal demise and 180 women (65%) with a live fetuses. Extra-amniotic PGE22 was administered in doses of 200 µg every 2 h up to 20 doses. Bumm curettage was performed in the majority of the patients. We compared the duration and complication rate between the groups. The median induction to abortion interval was significantly shorter in the fetal demise group (13 vs. 21 h) than in the live fetus group. Mean gestational ages and complication rates were similar. Midtrimester termination of pregnancy with extra-amniotic PGE22 is a safe method with a low complication rate. In cases of pregnancy with fetal demise extra-amniotic PGE22 is associated with a significantly shorter induction to abortion interval than with a live fetus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramovici H, Bornstein J, Ben-David Y, Yishai D, Rofe A, Atad J (1995) Double-balloon instillation device for second trimester abortion. Outcome in 340 consecutive cases. J Reprod Med 40:56–62

    Google Scholar 

  2. Ben-Arie A, Hazan Y, Goldchmit R, Hagay Z (2000) Safety of extraovular catheter insertion for second trimester abortion. Obstet Gynecol 96:29–32

    Google Scholar 

  3. Cabrol D, Bouvier M, Mermet E, Cedard I, Sureau C, Baulieu EE (1986) Induction du travail par le mifepristone (RU 486) dans les morts foetales in utero et les interruptions therapeutiques de grossesse. In: Control and management of partition. Eurotext 151:259–264. Colloque Inserm/Jhon Libbey, Paris

    Google Scholar 

  4. Cabrol D, Dubois C, Cronje J, Gonnet J, Guillot M, Ulmann A (1990) Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol 163:540–542

    Google Scholar 

  5. Cabrol D, Carbonne B, Dallot E, Josserand S, Caville FF (1996) Inhibition of prostaglandin E2 production in myometrial and amniotic cells in culture by human amniotic fluid. Loss of inhibition after intra-uterine fetal death. Eur J Obstet Gynecol Reprod Biol 64:135–140

    Google Scholar 

  6. Centers for Disease Control (1979–1980) Abortion surveillance. CDC, Atlanta

  7. Chapman SJ, Crispens M, Owen J, Savage RN (1996) Complications of midtrimester pregnancy termination: the effect of prior cesarean delivery. Am J Obstet Gynecol 175:889–892

    Google Scholar 

  8. Csapo AL (1997) The see-saw theory of parturition. Ciba Found Symp

  9. Fruzzetti F, Melis GB, De Cecco L, Genazzani AR, Fioretti P (1991) The use of 16:16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppositories for management of missed abortion and fetal death. Int J Gynaecol Obstet 26:115–119

    Google Scholar 

  10. Hagar L, Valley MT, Rayburn WF, Carey JC (1997) Midtrimester pregnancy termination for fetal malformation. Use of intravaginal prostaglandin E2. J Reprod Med 42:497–500

    Google Scholar 

  11. Hill MCW, MacKenzie IZ (1989) 2308 second trimester terminations using extra-amniotic or intra-amniotic prostaglandin E2: an analysis of efficacy and complications. Br J Obstet Gynaecol 96:1424–1431

    Google Scholar 

  12. Jain KJ, Mishell DR (1996) A comparison of misoprostol with and without laminaria tents for induction of second trimester abortion. Am J Obstet Gynecol 175:173–177

    Google Scholar 

  13. Jaschevatzky OE, Rosenberg RP, Noy Y,Dascalu S, Anderman S, Ballas S (1994) Comparative study of extra-amniotic prostaglandin F2 alpha infusion and increasing intravenous oxytocin for termination of second trimester missed abortion. J Am Coll Surg 178:435–438

    Google Scholar 

  14. Rouzi AA, Hawasawi H, Abduljabbar H (1999) Extraamniotic prostaglandin E2 for termination in the second and early third trimesters. Int J Gynaecol Obstet 67:45–46

    Google Scholar 

  15. Schiff E, Lipitz S, Ben-Baruch G, Chetrit A, Oelsner G, Menczer J (1990) Midtrimester abortion induction with intraamniotic prostaglandin F2 alpha in women with previous uterine surgery. J Reprod Med 3:198–200

    Google Scholar 

  16. Wiley TL, Poole KS, Gookin WL, Morrison JC (1989) Prostaglandin E2 induction of abortion and fetal demise. Int J Gynaecol Obstet 28:171–175

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Sacker Faculty of Medicine, Tel Aviv University, Holon 58100, Tel Aviv, Israel, Israel

    A. Debby, R. Sagiv, O. Girtler, O. Sadan, M. Glezerman & A. Golan

Authors
  1. A. Debby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Sagiv
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Girtler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Sadan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Glezerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Golan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Glezerman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debby, A., Sagiv, R., Girtler, O. et al. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise. Arch Gynecol Obstet 268, 301–303 (2003). https://doi.org/10.1007/s00404-002-0369-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-002-0369-5

Keywords.

Search

Navigation